Blood cancers, High grade lymphoma, Low grade lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial compared ofatumumab with rituximab for people with diffuse large B cell or follicular lymphoma. It was for people whose lymphoma had:
come back
continued to grow after treatment
Recruitment start: 1 December 2009
Recruitment end: 16 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Gustaaf W. van Imhoff
Dr Andrew McMillian (UK)
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
HOVON Dutch-Belgian Cooperative Trial Group for Hematology-Oncology
NIHR Clinical Research Network: Cancer
Last reviewed: 15 Nov 2018
CRUK internal database number: 5636
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
